BECTON, DICKINSON AND COMPANY Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
BECTON, DICKINSON AND COMPANY (BDX) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 12-month period ending 2024-09-30, per its 10-K filed 2024-11-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2024-11-27
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2023-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2022-06-30 was 38.00K shares.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2022-03-31 was 53.00K shares.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2024 was 0.00 shares.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2022 was 26.00K shares.
- BECTON, DICKINSON AND COMPANY incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2021 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2024-09-30 | 0.00 shares 10-K · filed 2024-11-27 | |||
| 2023-09-30 | 0.00 shares 10-K · filed 2024-11-27 | |||
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-03 | 0.00 shares 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-04 | 0.00 shares 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | 26.00K shares 10-K · filed 2024-11-27 | |||
| 2022-06-30 | 38.00K shares 10-Q · filed 2023-08-03 | 31.00K shares 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 53.00K shares 10-Q · filed 2023-05-04 | 26.00K shares 10-Q · filed 2023-05-04 | ||
| 2021-09-30 | 0.00 shares 10-K · filed 2023-11-21 | |||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-04 | 0.00 shares 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | 0.00 shares 10-Q · filed 2022-05-05 | ||
| 2020-09-30 | 0.00 shares 10-K · filed 2022-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |